moxifloxacin
KMU-IRB-970389
Approved small_molecule completed
Quick answer
moxifloxacin for Intra-abdominal Infection is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Intra-abdominal Infection
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed